Characterization of semi-solid Self-Emulsifying Drug Delivery Systems (SEDDS) of atorvastatin calcium by Raman image spectroscopy and chemometrics

Journal of Pharmaceutical and Biomedical Analysis

Volumn 73, Issue , 2013, Pages 3-12

  Breitkreitz, Márcia C ^a   Sabin, Guilherme P ^a   Polla, Griselda ^b   Poppi, Ronei J ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b DEPARTAMENTO DE FÍSICA   (Argentina)

Author keywords

Chemometrics; Lipid based formulations; Raman image spectroscopy

Indexed keywords

ATORVASTATIN; DIETHYLENE GLYCOL MONOETHYL ETHER; EXCIPIENT; GELUCIRE; OCTANOIN; PROPYLENE GLYCOL; PROPYLENE GLYCOL MONOCAPRYLATE; SOLVENT; UNCLASSIFIED DRUG;

ARTICLE; CHEMOMETRICS; CONCENTRATION (PARAMETERS); DILUTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; HYDROPHILICITY; LIPOPHILICITY; MISCIBILITY; POLARIZATION; PRIORITY JOURNAL; RAMAN SPECTROMETRY; SCREENING; SELF EMULSIFYING DRUG DELIVERY SYSTEM;

COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG CARRIERS; DRUG COMPOUNDING; EMULSIONS; HEPTANOIC ACIDS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MULTIVARIATE ANALYSIS; PHASE TRANSITION; POLYETHYLENE GLYCOLS; PYRROLES; REGRESSION ANALYSIS; SOLUBILITY; SOLVENTS; SPECTRUM ANALYSIS, RAMAN; SURFACE PROPERTIES; SURFACE-ACTIVE AGENTS;

EID: 84869497263     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.03.054     Document Type: Article

References (46)

1. Hauss D. Oral lipid-based formulations. Adv. Drug Deliv. Rev. 2007, 59:667-676.
2. Benet L.Z., Wu C.Y., Custodio J.M. Predicting drug absorption and the effects of food on oral bioavailability. Bull. Tech. Gattefosse 2006, 99:9-16.
3. Amidon G.L., Lennernäs H., Shah V.O., Crison J.R. A theoretical basis for a biopharmaceutics drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 1995, 12:413-420.
4. Cole E.T., Cadé D., Benameur H. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration. Adv. Drug Deliv. Rev. 2008, 60:747-756.
5. Strickley R.G. Solubilizing excipients in oral and injectable formulations. Pharm. Res. 2004, 21:201-230.
6. Janin V., Musakhanian J., Marchaud D. Approaches for the development of solid and semi-solid lipid-based formulations. Adv. Drug Deliv. Rev. 2008, 60:734-746.
7. Gibson L. Lipid-based excipients for oral drug delivery. Oral Lipid-Based Formulations: Enhancing the Bioavailability of Poorly Water-Soluble Drugs 2007, 33-61. Informa Healthcare USA Inc., New York. D. Hauss (Ed.).
8. Pouton C. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur. J. Pharm. Sci. 2006, 29:278-287.
9. ® 44/14. Drug Dev. Ind. Pharm. 2005, 31:527-534.
10. Damian F., Blaton N., Naesens L., Balzarini J., Kinget R., Augustijns P., van der Mooter G. Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur. J. Pharm. Sci. 2000, 10:311-322.
11. Karatas A., Yuksel N., Baykara T. Improved solubility and dissolution rate of Piroxican using Gelucire 44/14 and Labrasol. IL Farmaco 2005, 60:777-782.
12. Venkatesan K., Takada K. Gelucire 44/14 and Labrasol in enhancing oral absorption of poorly absorbable drugs. Bull. Tech. Gattefosse 2006, 99:79-88.
13. Schamp K., Schreder S.A., Dressman J. Development of an in vitro/in vivo correlation for lipid formulations of EMD 51733 a poorly soluble, lipophilic substance. Eur. J. Pharm. Biopharm. 2006, 62:227-234.
14. Jannin V. The application of Gattefosse products: a 2005-2006 literature review. Bull. Tech. Gattefosse 2006, 99:103-111.
15. Barker S.A., Yap S.P., Yuen K.H., McCoy C.P., Murphy J.R., Craig D.Q.M. An investigation into the structure and bioavailability of α-tocopherol dispersions in Gelucire 44/14. J. Control. Release 2003, 91:477-488.
16. Breitenbach J., Schrof W., Neumann J. Confocal Raman spectroscopy: analytical approach to solid dispersions and mapping of drugs. Pharm. Res. 1999, 16:1109-1113.
17. Furuyama N., Hasegawa S., Hamaura T., Yada S., Nakagami H., Yonemochi E., Terada K. Evaluation of solid dispersions on a molecular level by Raman mapping technique. Int. J. Pharm. 2008, 36:12-18.
18. Docoslis A., Huszarik K.L., Papageorgiou G.Z., Bikiaris D., Stergiou A., Georgarakis E. Characterization of the distribution, polymorphism, and stability of nimodipine in its solid dispersions in polyethylene glycol by micro-Raman spectroscopy and powder X-ray diffraction. AAPS J. 2007, 9:E361-E370.
19. Windbergs M., Jurna M., Offerhaus H.L., Herek J.L., Kleinebudde P., Strachan C.J. Chemical imaging of oral solid dosage forms and changes upon dissolution using coherent anti-stokes Raman scattering microscopy. Anal. Chem. 2009, 81:2085-2209.
20. Sasic S. An in-depth analysis of Raman and near infrared chemical images of common pharmaceutical tablets. Appl. Spec. 2007, 61:239-250.
21. Z.K. Nagy, M. Sauceau, K. Nyul, E. Rodier, B. Vajna, G. Marosi, J. Fages, Use of supercritical CO2-aided and conventional melt extrusion for enhancing the dissolution rate of an active pharmaceutical ingredient, Polym. Adv. Technol., doi:10.1002/pat.1991.
22. Nagy Z.K., Balogh A., Vajna B., Farkas A., Patyl G., Kramarics A. Comparison of electrospun and extruded soluplus-based solid dosage forms of improved dissolution. J. Pharm. Sci. 2012, 101:322-332.
23. Amigo J.M., Ravn C., Gallagher N.B., Bro R. A comparison of a common approach to partial least squares-discriminant analysis and classical least squares in hyperspectral imaging. Int. J. Pharm. 2009, 373:179-182.
24. Li P., Hynes S.R., Haefele T.F., Pudipeddi M., Royce A.E., Serajuddin A.T.M. Development of clinical dosage forms for a poorly water-soluble drug. II. Formulation and characterization of a novel solid microemulsion preconcentrate system for oral delivery of a poorly water-soluble drug. J. Pharm. Sci. 2009, 98:1750-1764.
25. de Juan A., Tauler R., Dyson R., Marcolli C., Rault M., Maeder M. Spectroscopic imaging and chemometrics: a powerful combination for global and local sample analysis. Trends Anal. Chem. 2004, 23:70-79.
26. Amigo J.M., Ravn C. Direct quantification and distribution assessment of major and minor components in pharmaceutical tablet by NIR-chemical imaging. Eur. J. Pharm. Sci. 2009, 37:76-82.
27. Vajna B., Pataki H., Nagy Z., Farkas I., Marosi G. Characterization of melt extruded and conventional isoptin formulations using Raman chemical imaging and chemometrics. Int. J. Pharm. 2011, 419:107-113.
28. Vajna B., Farkas I., Farkas A., Pataki H., Nagy Z. Characterization of drug-cylodextrin formulations using Raman mapping and multivariate curve resolution. J. Pharm. Biomed. Anal. 2011, 56:38-44.
29. Gendrin C., Roggo Y., Collet C. Content uniformity of pharmaceutical solid dosage forms by near infrared hyperspectral imaging: a feasibility study. Talanta 2007, 73:733-741.
30. Ravn C., Skibdted E., Bro R. Near Infrared chemical imaging (NIR-CI) on pharmaceutical solid dosage forms - comparing common calibration approaches. J. Pharm. Biomed. Anal. 2008, 48:554-561.
31. Amigo J.M., Cruz J., Bautista M., Maspoch S., Coello J., Blanco M. Study of pharmaceutical samples by NIR chemical-image and multivariate analysis. Trends Anal. Chem. 2008, 27:696-713.
32. Zhang L., G M.J., Sekulic S.S. Multivariate data analysis for Raman imaging of a model pharmaceutical tablet. Anal. Chim. Acta 2005, 545:262-278.
33. Reich G. Near infrared spectroscopy and imaging: basic principles and pharmaceutical applications. Adv. Drug Deliv. Rev. 2000, 57:1109-1143.
34. Gendrin C., Roggo Y., Collet C. Pharmaceutical applications of vibrational chemical imaging and chemometrics: a review. J. Pharm. Biomed. Anal. 2008, 48:533-553.
35. Gordon K.C., McGoverinF C.M. Raman mapping of pharmaceuticals. Int. J. Pharm. 2011, 417:151-162.
36. Gowen A.A., O'Donnell C.P., Cullen P.J., Bell S.E.J. Recent applications of chemical imaging to pharmaceutical process monitoring and quality control. Eur. J. Pharm. Biopharm. 2008, 69:10-22.
37. Amigo J.M. Practical issues of hyperspectral imaging analysis of solid dosage forms. Anal. Bioanal. Chem. 2010, 398:93-109.
38. Shen H.R., Zhong M. Preparation and evaluation of self-microemulsifying drug delivery system (SMEDDS) containing atorvastatin. J. Pharm. Pharmacol. 2006, 58:1183-1191.
39. Arunkumar N., Deecaraman M., Rani C., Mohanraj K.P., Kumar K.V. Preparation and solid state characterization of atorvastatin nanosuspensions for enhanced solubility and dissolution. Int. J. PharmTech. Res. 2009, 1:1725-1730.
40. Yin Y.M., Cui F.D., Kim J.S., Choi M.K., Choi B.C., Chung S.J., Shim C.K., Kim D.D. Preparation, characterization and in vitro intestinal absorption of a dry emulsion formulation containing atorvastatin calcium. Drug Deliv. 2009, 16:30-36.
41. Kadu P.J., Kushare S.S., Thacker D.D., Gattani S.G. Enhancement of oral bioavailability of atorvastatin calcium by Self-Emulsifying Drug Delivery Systems (SEDDS). Pharm. Dev. Technol. 2011, 16:65-74.
42. Food and Drug Administration, Center of Drug Evaluation and Research (CDER), Guidance for Industry: Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System, Rockville, 2000.
43. Geladi P., Kowalski B.R. PLS Tutorial. Anal. Chim. Acta 1986, 185:1-16.
44. Martens H., Næs T. Multivariate Calibration 1989, John Wiley & Sons, New York.
45. Zhang L., Henson M.J. A practical algorithm to remove cosmic spikes in Raman imaging data for pharmaceutical applications. Appl. Spectrosc. 2007, 61:1015.
46. Kasim N.A., Whitehouse M., Ramachandran C., Bermejo M., Lennernäs H., Hussain A.S., Junginger H.E., Stavchansky S.A., Midha K.K., Shah V.P., Amidon G.L. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol. Pharm. 2003, 1:85-96.